Exscientia Plc (EXAI) Financials
EXAI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 671.0 million | 191.7 million |
2023-06-30 | 711.9 million | 185.2 million |
2023-03-31 | 747.5 million | 192.7 million |
2022-12-31 | 949.5 million | 249.7 million |
EXAI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -46.6 million | 7.8 million |
2023-06-30 | -60.4 million | 8.6 million |
2023-03-31 | -69.6 million | 8.6 million |
2022-12-31 | -80.8 million | 12.6 million |
EXAI Net Income
No data available :(
EXAI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 447.2 million | - | 21.9 million |
2023-06-30 | 505.2 million | - | 23.3 million |
2023-03-31 | 554.3 million | - | 23.8 million |
2022-12-31 | 739.3 million | - | 19.9 million |
EXAI Shares Outstanding
EXAI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 4.9 million | 38.7 million | 13.6 million | - |
2023-06-30 | 8.3 million | 39.8 million | 14.7 million | - |
2023-03-31 | 15.8 million | 41.4 million | 13.5 million | - |
2022-12-31 | 10.4 million | 52.0 million | 12.0 million | - |
EXAI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 10.8 million | 8.2 million |
2023-06-30 | 3.8 million | 7.9 million |
2023-03-31 | 7.1 million | 10.5 million |
2022-12-31 | 9.9 million | 13.9 million |
EXAI
Price: $4.97
52 week price:
Earnings Per Share: -1.49 USD
P/E Ratio: -4.02
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 445040
Market Capitalization: 626.8 million